Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rupinder Brar

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
Journal of Addiction Medicine|March 4, 2022
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder TreatmentLaura MacKinnon, JinCheol Choi, Mary Clare Kennedy, et al.
Harm Reduction Journal|November 24, 2022
Self-injecting non-prescribed substances into vascular access devices: a case study of one health system's ongoing journey from clinical concern to practice and policy responseJocelyn Chase, Melissa Nicholson, Elizabeth Dogherty, et al.
Journal of Addiction Medicine|March 7, 2020
Factors Associated With the Use of Supervised Consumption Facilities Among Women Who Inject Drugs in a Canadian SettingSarah Ickowicz, Cameron Grant, Ekaterina Nosova, et al.
Canadian Family Physician Medecin De Famille Canadien|December 15, 2021
Inability to access primary care clinics among people who inject drugs in a Canadian health care settingRupinder Brar, M-J Milloy, Kora DeBeck, et al.
The International Journal on Drug Policy|February 13, 2020
Trajectories of retention in opioid agonist therapy in a Canadian settingM Eugenia Socías, Huiru Dong, Evan Wood, et al.
The International Journal on Drug Policy|June 4, 2023
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysisM Eugenia Socias, Jin Cheol Choi, Nadia Fairbairn, et al.
Drug and Alcohol Dependence|April 1, 2018
Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, CanadaJan Klimas, Ekaterina Nosova, Eugenia Socías, et al.
Addiction Science & Clinical Practice|December 15, 2022
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapySoroush Moallef, Kora DeBeck, Nadia Fairbairn, et al.
Journal of Pathology and Translational Medicine|September 21, 2022
Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn's disease: image processing and analysis studyMustafa Erdem Arslan, Rupinder Brar, Lianna Goetz, et al.
Journal of Substance Use and Addiction Treatment|September 8, 2023
Correlates of nonfatal overdose among treatment-seeking individuals with non-heroin opioid use disorder: Findings from a pragmatic, pan-Canadian, randomized control trialHannah Crepeault, Lianping Ti, Didier Jutras-Aswad, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
Journal of Addiction Medicine|March 4, 2022
Medical Detoxification for Nonopioid Substances Is Associated With Lower Likelihood of Subsequent Linkage to Substance Use Disorder TreatmentLaura MacKinnon, JinCheol Choi, Mary Clare Kennedy, et al.
Harm Reduction Journal|November 24, 2022
Self-injecting non-prescribed substances into vascular access devices: a case study of one health system's ongoing journey from clinical concern to practice and policy responseJocelyn Chase, Melissa Nicholson, Elizabeth Dogherty, et al.
Journal of Addiction Medicine|March 7, 2020
Factors Associated With the Use of Supervised Consumption Facilities Among Women Who Inject Drugs in a Canadian SettingSarah Ickowicz, Cameron Grant, Ekaterina Nosova, et al.
Canadian Family Physician Medecin De Famille Canadien|December 15, 2021
Inability to access primary care clinics among people who inject drugs in a Canadian health care settingRupinder Brar, M-J Milloy, Kora DeBeck, et al.
The International Journal on Drug Policy|February 13, 2020
Trajectories of retention in opioid agonist therapy in a Canadian settingM Eugenia Socías, Huiru Dong, Evan Wood, et al.
The International Journal on Drug Policy|June 4, 2023
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysisM Eugenia Socias, Jin Cheol Choi, Nadia Fairbairn, et al.
Drug and Alcohol Dependence|April 1, 2018
Factors associated with discontinuation of methadone maintenance therapy (MMT) among persons who use alcohol in Vancouver, CanadaJan Klimas, Ekaterina Nosova, Eugenia Socías, et al.
Addiction Science & Clinical Practice|December 15, 2022
Inability to contact opioid agonist therapy prescribers during the COVID-19 pandemic in a Canadian setting: a cross-sectional analysis among people on opioid agonist therapySoroush Moallef, Kora DeBeck, Nadia Fairbairn, et al.
Journal of Pathology and Translational Medicine|September 21, 2022
Inflammation and tissue remodeling contribute to fibrogenesis in stricturing Crohn's disease: image processing and analysis studyMustafa Erdem Arslan, Rupinder Brar, Lianna Goetz, et al.
Journal of Substance Use and Addiction Treatment|September 8, 2023
Correlates of nonfatal overdose among treatment-seeking individuals with non-heroin opioid use disorder: Findings from a pragmatic, pan-Canadian, randomized control trialHannah Crepeault, Lianping Ti, Didier Jutras-Aswad, et al.
Pageof 4